MorphoSys AG Statistics
Total Valuation
MorphoSys AG has a market cap or net worth of $2.71 billion. The enterprise value is $3.91 billion.
Market Cap | 2.71B |
Enterprise Value | 3.91B |
Important Dates
The next estimated earnings date is Wednesday, May 1, 2024, after market close.
Earnings Date | May 1, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MorphoSys AG has 150.65 million shares outstanding.
Shares Outstanding | 150.65M |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 16.00% |
Float | 33.15M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 322.58 |
PS Ratio | 10.25 |
Forward PS | 13.98 |
PB Ratio | 51.95 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 14.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.08, with a Debt / Equity ratio of 36.87.
Current Ratio | 3.08 |
Quick Ratio | 2.71 |
Debt / Equity | 36.87 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.34 |
Financial Efficiency
Return on equity (ROE) is -183.80% and return on invested capital (ROIC) is -13.59%.
Return on Equity (ROE) | -183.80% |
Return on Assets (ROA) | -8.60% |
Return on Capital (ROIC) | -13.59% |
Revenue Per Employee | $505,255 |
Profits Per Employee | -$402,320 |
Employee Count | 524 |
Asset Turnover | 0.11 |
Inventory Turnover | 1.28 |
Taxes
Income Tax | -1.27M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +247.12% in the last 52 weeks. The beta is 0.60, so MorphoSys AG's price volatility has been lower than the market average.
Beta (1Y) | 0.60 |
52-Week Price Change | +247.12% |
50-Day Moving Average | 17.84 |
200-Day Moving Average | 10.48 |
Relative Strength Index (RSI) | 60.20 |
Average Volume (30 Days) | 1,891,188 |
Short Selling Information
Short Interest | 1.63M |
Short Previous Month | 2.09M |
Short % of Shares Out | 0.09% |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.54 |
Income Statement
In the last 12 months, MorphoSys AG had revenue of $264.75 million and -$210.82 million in losses. Loss per share was -$1.47.
Revenue | 264.75M |
Gross Profit | 191.58M |
Operating Income | -268.83M |
Pretax Income | -203.29M |
Net Income | -210.82M |
EBITDA | -40.90M |
EBIT | -52.11M |
Loss Per Share | -$1.47 |
Balance Sheet
The company has $726.97 million in cash and $1.93 billion in debt, giving a net cash position of -$1.20 billion or -$7.96 per share.
Cash & Cash Equivalents | 726.97M |
Total Debt | 1.93B |
Net Cash | -1.20B |
Net Cash Per Share | -$7.96 |
Equity / Book Value | 52.23M |
Book Value Per Share | 0.35 |
Working Capital | 585.31M |
Cash Flow
In the last 12 months, operating cash flow was -$314.99 million and capital expenditures -$372,098, giving a free cash flow of -$315.37 million.
Operating Cash Flow | -314.99M |
Capital Expenditures | -372,098 |
Free Cash Flow | -315.37M |
FCF Per Share | -$2.30 |
Margins
Gross margin is 72.36%, with operating and profit margins of -101.54% and -79.63%.
Gross Margin | 72.36% |
Operating Margin | -101.54% |
Pretax Margin | -76.78% |
Profit Margin | -79.63% |
EBITDA Margin | -15.45% |
EBIT Margin | -19.68% |
FCF Margin | -119.12% |
Dividends & Yields
MorphoSys AG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.46% |
Shareholder Yield | -0.46% |
Earnings Yield | -7.77% |
FCF Yield | -11.62% |
Analyst Forecast
The average price target for MorphoSys AG is $12.13, which is -32.61% lower than the current price. The consensus rating is "Hold".
Price Target | $12.13 |
Price Target Difference | -32.61% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 33.94% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MorphoSys AG has an Altman Z-Score of 0.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.44 |
Piotroski F-Score | 2 |